Q
Quince Therapeutics, Inc. (QNCX)
NMS – Real vaqt narxi. Valyuta: USD
31.26
-1.47 (-4.49%)
Yopilishda: Aug 12, 2026, 4:00 PM EDT
31.26
0.00 (0.00%)
Bozordan keyin: Aug 12, 2026, 4:10 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NMS – Real vaqt narxi. Valyuta: USD
31.26
-1.47 (-4.49%)
Yopilishda: Aug 12, 2026, 4:00 PM EDT
31.26
0.00 (0.00%)
Bozordan keyin: Aug 12, 2026, 4:10 PM EDT
Quince Therapeutics, Inc., biotexnologiya kompaniyasi, nogironlik va kam uchraydigan kasalliklarga chalingan bemorlar uchun terapevtik vositalarni sotib olish, ishlab chiqish va tijoratlashtirishga qaratilgan. Kompaniyaning asosiy dori nomzodi eDSP bo'lib, u kam uchraydigan pediatrik neyrodegenerativ kasalliklarni, shu jumladan ATM genidagi mutatsiyalar tufayli kelib chiqqan irsiy autosomal resessiv neyrodegenerativ va immunitet tanqisligi buzilishi bo'lgan A-Tni davolash uchun 3-bosqichda. Uning AIDE texnologik platformasi, dori/jihoz kombinatsiyasi platformasi bo'lib, u dori vositasini bemorning o'z eritrotsitlariga kapsulalash uchun avtomatlashtirilgan jarayonni qo'llaydi, shuningdek, RCL avtomatlashtirilgan uskunalaridan, tibbiy jihozlar, shprits to'plami va jarayon eritmalarini o'z ichiga olgan steril bir martalik sarflanadigan davolash to'plamidan iborat. Kompaniya ilgari Cortexyme, Inc. nomi bilan tanilgan va 2022 yil avgust oyida Quince Therapeutics, Inc. nomini o'zgartirgan. Kompaniya 2012 yilda tashkil etilgan va Kaliforniyaning Janubiy San-Frantsisko shahrida joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Brigette Roberts M.D. | Chief Corporate Affairs Officer & Director |
| Dr. Charles S. Ryan J.D., Ph.D. | President |
| Dr. Dirk Thye M.D. | CEO, Chief Medical Officer & Director |
| Dr. Guenter R. Janhofer M.D., Ph.D. | Chief Scientific Officer |
| Dr. Keith Fandrick Ph.D. | Head of Technical Operations |
| Mr. Brendan Hannah M.B.A. | Chief Business Officer, COO, Chief Compliance Officer and Principal Financial & Accounting Officer |
| Mr. John C. Militello CPA | Head of Finance |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-08-05 | S-3/A | d112732ds3a.htm |
| 2026-07-31 | PRE 14A | d46981dpre14a.htm |
| 2026-07-31 | 8-K | d160394d8k.htm |
| 2026-07-30 | 8-K/A | d163930d8ka.htm |
| 2026-06-26 | 8-K/A | d30985d8ka.htm |
| 2026-06-26 | 8-K | d168420d8k.htm |
| 2026-06-11 | 8-K | d124733d8k.htm |
| 2026-05-21 | 8-K | d139014d8k.htm |
| 2026-05-18 | 8-K/A | d135388d8ka.htm |
| 2026-05-18 | 8-K | d109149d8k.htm |